The event focuses on recent advances in rare neurological and neurodevelopmental disorders across the lifespan. Topics include the transition of neurodevelopmental disorders from childhood to adulthood, new perspectives on autoimmune encephalitis, and challenges in rare childhood neurological disorders from clinical care to cellular research models. Emerging therapies such as N-Acetyl-L-Leucine and Fampridine for rare neurological diseases are discussed, alongside new insights into the expanding spectrum of rare dystonic syndromes and future precision medicine approaches.